$1.03 Billion is the total value of Broadfin Capital, LLC's 85 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 81.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $70,590,000 | +132.7% | 5,267,911 | +39.8% | 6.84% | +70.9% |
| HZNP | Buy | HORIZON PHARMA INC | $65,099,000 | +100.7% | 4,305,469 | +1.1% | 6.31% | +47.4% |
| DEPO | Sell | DEPOMED INC | $46,267,000 | -7.8% | 3,190,816 | -32.8% | 4.48% | -32.3% |
| EBS | Buy | EMERGENT BIOSOLUTIONS INC | $45,621,000 | +84.8% | 1,805,352 | +68.1% | 4.42% | +35.7% |
| ANGO | Buy | ANGIODYNAMICS INC | $40,834,000 | -4.7% | 2,592,649 | +3.8% | 3.96% | -30.0% |
| RTRX | New | RETROPHIN INC | $34,126,000 | – | 1,609,696 | +100.0% | 3.31% | – |
| HRTX | New | HERON THERAPEUTICS INC | $31,063,000 | – | 2,233,173 | +100.0% | 3.01% | – |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $29,304,000 | +123.9% | 3,472,054 | +56.3% | 2.84% | +64.5% |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $27,329,000 | -15.9% | 1,226,617 | -37.7% | 2.65% | -38.2% |
| LCI | Sell | LANNET INC | $24,417,000 | -44.9% | 683,564 | -49.0% | 2.36% | -59.6% |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $22,847,000 | +7.2% | 5,586,169 | +39.7% | 2.21% | -21.3% |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $21,868,000 | -26.3% | 2,008,125 | -8.4% | 2.12% | -45.8% |
| DSCI | Buy | DERMA SCIENCES INC | $21,173,000 | +124.5% | 1,669,777 | +91.6% | 2.05% | +64.9% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $21,166,000 | +49.9% | 5,455,119 | +10.1% | 2.05% | +10.0% |
| CTRX | New | CATAMARAN CORP | $20,959,000 | – | 468,263 | +100.0% | 2.03% | – |
| ANAC | Sell | ANACOR PHARMACEUTICALS INC | $20,027,000 | -21.3% | 1,000,869 | -34.0% | 1.94% | -42.2% |
| NTUS | Sell | NATUS MEDICAL INC DEL | $19,735,000 | -13.5% | 764,915 | -24.6% | 1.91% | -36.5% |
| DSCO | DISCOVERY LABORATORIES INC N | $17,342,000 | -4.4% | 8,066,000 | 0.0% | 1.68% | -29.8% | |
| AMAG | New | AMAG PHARMACEUTICALS INC | $16,779,000 | – | 867,117 | +100.0% | 1.62% | – |
| IPXL | Sell | IMPAX LABORATORIES INC | $16,748,000 | -9.2% | 633,929 | -13.6% | 1.62% | -33.4% |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $16,163,000 | – | 350,000 | +100.0% | 1.57% | – |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $15,766,000 | +14.6% | 1,326,000 | +33.1% | 1.53% | -15.8% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $15,410,000 | -54.3% | 291,636 | -65.4% | 1.49% | -66.4% |
| PTX | New | PERNIX THERAPEUTICS HLDGS IN | $14,980,000 | – | 3,500,000 | +100.0% | 1.45% | – |
| ZGNX | Sell | ZOGENIX INC | $14,617,000 | -27.7% | 5,137,645 | -12.6% | 1.42% | -46.9% |
| EBIO | New | ELEVEN BIOTHERAPEUTICS INC | $13,989,000 | – | 861,933 | +100.0% | 1.36% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $13,846,000 | -2.6% | 7,660,100 | +5.7% | 1.34% | -28.4% |
| ATRC | Buy | ATRICURE INC | $13,402,000 | +64.0% | 712,495 | +62.9% | 1.30% | +20.4% |
| IDRA | Sell | IDERA PHARMACEUTICALS INC | $13,059,000 | -20.6% | 3,200,700 | -9.8% | 1.26% | -41.7% |
| ELOS | Buy | SYNERON MEDICAL LTD | $12,515,000 | +408.7% | 1,005,221 | +402.6% | 1.21% | +274.1% |
| PETX | New | ARATANA THERAPEUTICS INC | $12,388,000 | – | 667,435 | +100.0% | 1.20% | – |
| LBMH | Buy | LIBERATOR MEDICAL HLDGS INC | $12,020,000 | +32.9% | 3,058,644 | +41.0% | 1.16% | -2.4% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $11,174,000 | -43.9% | 411,100 | -57.2% | 1.08% | -58.8% |
| CEMP | Sell | CEMPRA INC | $11,032,000 | -23.5% | 955,147 | -18.0% | 1.07% | -43.8% |
| OCR | New | OMNICARE INC | $10,442,000 | – | 175,000 | +100.0% | 1.01% | – |
| MOH | Buy | MOLINA HEALTHCARE INC | $10,329,000 | +29.6% | 275,000 | +19.9% | 1.00% | -4.8% |
| XNCR | Sell | XENCOR INC | $9,089,000 | +13.8% | 774,881 | -11.3% | 0.88% | -16.5% |
| SGNT | Buy | SAGENT PHARMACEUTICALS INC | $8,885,000 | +8.9% | 380,188 | +18.3% | 0.86% | -20.0% |
| POZN | Sell | POZEN INC | $8,665,000 | -6.7% | 1,083,087 | -6.3% | 0.84% | -31.5% |
| IG | IGI LABS INC | $8,475,000 | +85.2% | 1,500,000 | 0.0% | 0.82% | +36.2% | |
| ATRS | Buy | ANTARES PHARMA INC | $8,050,000 | +125.0% | 2,300,000 | +187.5% | 0.78% | +65.3% |
| CCXI | Buy | CHEMOCENTRYX INC | $6,962,000 | +16.3% | 1,050,000 | +1.6% | 0.67% | -14.6% |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $6,499,000 | – | 510,500 | +100.0% | 0.63% | – |
| UAM | New | UNIVERSAL AMERN CORP NEW | $6,233,000 | – | 881,605 | +100.0% | 0.60% | – |
| DRRX | Sell | DURECT CORP | $5,858,000 | -37.8% | 4,404,495 | -19.0% | 0.57% | -54.3% |
| OXBT | New | OXYGEN BIOTHERAPEUTICS INC | $5,510,000 | – | 992,857 | +100.0% | 0.53% | – |
| AIRM | New | AIR METHODS CORP | $5,343,000 | – | 100,000 | +100.0% | 0.52% | – |
| RXDX | New | IGNYTA INC | $5,326,000 | – | 641,700 | +100.0% | 0.52% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $5,247,000 | – | 254,068 | +100.0% | 0.51% | – |
| TNXP | Buy | TONIX PHARMACEUTICALS HLDG C | $4,868,000 | +20.2% | 467,639 | +19.0% | 0.47% | -11.6% |
| RXII | New | RXI PHARMACEUTICALS CORP NEW | $4,810,000 | – | 1,126,482 | +100.0% | 0.47% | – |
| TRVN | New | TREVENA INC | $4,716,000 | – | 600,000 | +100.0% | 0.46% | – |
| DPRX | New | DIPEXIUM PHARMACEUTICALS INC | $4,635,000 | – | 459,800 | +100.0% | 0.45% | – |
| REPH | New | RECRO PHARMA INC | $4,612,000 | – | 630,000 | +100.0% | 0.45% | – |
| QLTI | QLT INC | $4,364,000 | -0.2% | 784,893 | 0.0% | 0.42% | -26.7% | |
| THOR | New | THORATEC CORP | $4,364,000 | – | 121,867 | +100.0% | 0.42% | – |
| FLXN | New | FLEXION THERAPEUTICS INC | $4,330,000 | – | 263,204 | +100.0% | 0.42% | – |
| PTIE | Sell | PAIN THERAPEUTICS INC | $4,290,000 | -28.2% | 780,000 | -36.6% | 0.42% | -47.2% |
| INO | New | INOVIO PHARMACEUTICALS INC | $4,163,000 | – | 1,250,000 | +100.0% | 0.40% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $4,077,000 | – | 224,234 | +100.0% | 0.40% | – |
| BOTA | New | BIOTA PHARMACEUTIALS INC | $3,890,000 | – | 636,700 | +100.0% | 0.38% | – |
| RDHL | New | REDHILL BIOPHARMA LTDsponsored ads | $3,708,000 | – | 263,160 | +100.0% | 0.36% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $3,644,000 | -75.4% | 151,655 | -79.1% | 0.35% | -81.9% |
| BIOD | Buy | BIODEL INC | $3,631,000 | +59.3% | 1,330,034 | +33.0% | 0.35% | +16.9% |
| OMER | New | OMEROS CORP | $3,621,000 | – | 300,000 | +100.0% | 0.35% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $3,523,000 | -1.2% | 184,756 | -13.8% | 0.34% | -27.4% |
| AGEN | New | AGENUS INC | $3,344,000 | – | 1,055,000 | +100.0% | 0.32% | – |
| ACHN | ACHILLION PHARMACEUTICALS IN | $3,290,000 | -0.9% | 1,000,000 | 0.0% | 0.32% | -27.2% | |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $3,240,000 | – | 300,000 | +100.0% | 0.31% | – |
| CASM | Buy | CAS MED SYS INC | $3,092,000 | +34.7% | 1,424,796 | +5.6% | 0.30% | -1.0% |
| CLTX | New | CELSUS THERAPEUTICS PLCsponsored adr ne | $3,056,000 | – | 470,877 | +100.0% | 0.30% | – |
| OFIX | New | ORTHOFIX INTL N V | $3,015,000 | – | 100,000 | +100.0% | 0.29% | – |
| MELA | New | MELA SCIENCES INC | $2,967,000 | – | 4,000 | +100.0% | 0.29% | – |
| TXMD | Sell | THERAPEUTICSMD INC | $2,895,000 | -73.9% | 458,859 | -78.4% | 0.28% | -80.8% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $2,690,000 | – | 200,000 | +100.0% | 0.26% | – |
| VCRA | New | VOCERA COMMUNICATIONS INC | $2,623,000 | – | 160,597 | +100.0% | 0.25% | – |
| ANTH | ANTHERA PHARMACEUTICALS INC | $2,567,000 | +9.1% | 766,329 | 0.0% | 0.25% | -19.7% | |
| CUTR | CUTERA INC | $2,417,000 | +10.0% | 215,962 | 0.0% | 0.23% | -19.3% | |
| ACRX | ACELRX PHARMACEUTICALS INC | $2,402,000 | +6.2% | 200,000 | 0.0% | 0.23% | -21.8% | |
| NSPH | New | NANOSPHERE INC | $2,150,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $1,810,000 | – | 1,000,000 | +100.0% | 0.18% | – |
| CRME | New | CARDIOME PHARMA CORP | $1,582,000 | – | 200,000 | +100.0% | 0.15% | – |
| BIOS | New | BIOSCRIP INC | $1,536,000 | – | 220,000 | +100.0% | 0.15% | – |
| DRAD | Buy | DIGIRAD CORP | $1,140,000 | +37.2% | 332,480 | +48.1% | 0.11% | 0.0% |
| CRDC | Sell | CARDICA INC | $641,000 | -86.2% | 640,346 | -86.6% | 0.06% | -89.9% |
| STJ | Exit | ST JUDE MED INC | $0 | – | -100 | -100.0% | -0.00% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -15,000 | -100.0% | -0.04% | – |
| TRGT | Exit | TARGACEPT INC | $0 | – | -298,909 | -100.0% | -0.16% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -100,000 | -100.0% | -0.27% | – |
| DRTX | Exit | DURATA THERAPEUTICS INC | $0 | – | -188,706 | -100.0% | -0.32% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -500,000 | -100.0% | -0.33% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -150,000 | -100.0% | -0.64% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -543,466 | -100.0% | -0.72% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -391,232 | -100.0% | -0.93% | – |
| VTUS | Exit | VENTRUS BIOSCIENCES INC | $0 | – | -1,849,839 | -100.0% | -0.93% | – |
| SLTM | Exit | SOLTA MED INC | $0 | – | -3,356,391 | -100.0% | -1.31% | – |
| P103PS | Exit | NPS PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -1.60% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.